Katalog der Deutschen Nationalbibliothek

Go to:

Catalogue (Beta)

Knowledge Web

Person
Person

Person

Nicolas Kahn (1982-)

Arzt

Name

Nicolas Kahn

Time

1982- (Date of birth and death)

Place

Buenos Aires (Geburtsort)
Deutschland

Gender

männlich

Academic degree

Dr. med. (an der Medizinischen Fakultät der Universität Heidelberg) (2012)

Profession

Arzt (characteristic profession)

Variant

Nicolas C. Kahn
Nicolas Carlos Kahn

Further information

Pneumologe, Assistenzarzt, Abteilung Pneumologie und Beatmungsmedizin, Thoraxklinik, Universitätsklinikum Heidelberg

Record type

Person

GND-Identifier

1023650371

Record ID

1023650371

Involved in

show all

Is YouTube a sufficient source of information on Sarcoidosis?

Severe tracheal tear – an alternative extracorporeal membrane oxygenation indication

How Informed Are German Patients with Pulmonary Sarcoidosis about Their Disease?

Leitlinie zu Evaluation und Management von pulmonalen Manifestationen bei Sjögren-Syndrom

YouTube-videos for patient education in lymphangioleiomyomatosis?

Leitlinie zu Evaluation und Management von pulmonalen Manifestationen bei Sjögren-Syndrom

Nebenwirkungsprofil von Prednisolon und Methotrexat bei Patienten mit Sarkoidose

Nebenwirkungsprofil von Prednisolon und Methotrexat bei Patienten mit Sarkoidose

Cost drivers in the pharmacological treatment of interstitial lung disease

Azathioprine for Connective Tissue Disease-Associated Interstitial Lung Disease: In Search for Evidence-Based Medicine

Prädiktoren für Progression und Mortalität bei Patienten mit RA-assoziierter ILD

Determinants of health-related quality of life decline in interstitial lung disease

Ongoing challenges in pulmonary fibrosis and insights from the nintedanib clinical programme

SARS ‐CoV‐2 receptor ACE 2 and TMPRSS 2 are primarily expressed in bronchial transient secretory cells

Effects of Vibration Training in Interstitial Lung Diseases: A Randomized Controlled Trial

A Comparison of Existing Questionnaires for Identifying the Causes of Interstitial and Rare Lung Diseases

Bronchiolitis als mögliche unerwünschte Wirkung von Immuncheckpoint-Inhibitoren

Organisierende Pneumonie als seltene, unerwünschte Wirkung von Tocilizumab bei der Therapie von rheumatoider Arthritis

Possible value of antifibrotic drugs in patients with progressive fibrosing non-IPF interstitial lung diseases

The clinical course of idiopathic pulmonary fibrosis and its association to quality of life over time: longitudinal data from the INSIGHTS-IPF registry

C-proSP-B: A Possible Biomarker for Pulmonary Diseases?

Blood-sampling collection prior to surgery may have a significant influence upon biomarker concentrations measured

Gen-Expressions-Analysen aus endobronchialer epithelialer Flüssigkeit zur Abklärung pulmonaler Rundherde
Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

DNB portal